🔬 NIH-funded research is shedding light on genetic risk factors for liver cancer.
Researchers analyzed data from more than 290,000 people, including 208,000+ All of Us Research participants, and found that rare variants in the DNA repair genes MSH6 and BRCA2 are associated with
NIH invites innovators to join the NOURISH: Autoimmunity Digital Health Challenge!
Develop digital health tools that help people living with or at risk for autoimmune diseases monitor diet, nutrition & symptoms.
💰 Up to $650K in total prizes
🏆 Up to 10 Phase 1 awards of $20K
Preparing the future. Those three words describe Dr. James Maiarana's experience at NIH as a clinical fellow at the National Institute of Allergy and Infectious Diseases.
The opportunity to work side-by-side with experts who are advancing the future of medicine creates an
Cisplatin is one of the most effective cancer drugs we have — but it comes with a tough tradeoff: permanent hearing loss in up to half of patients who receive it.
NIH scientists led by Dr. Lisa Cunningham are testing whether a common cholesterol drug, atorvastatin, can reduce
NIH’s National Institute on Deafness and Other Communication Disorders (NIDCD) wants to hear from you!
NIDCD seeks comments and suggestions from the public in response to this question:
Are there new and emerging areas of science with the potential to impact the health and
